Company

About FIM

FIM builds AI products and research tools, operating from Beijing and Singapore.

What We Do

FIM is an AI product company with two product lines. Zico is a self-hosted contract lifecycle management platform, running in production at enterprise groups. One is a model-agnostic enterprise agent platform, source-available and self-hostable. Around our research work we also build a set of research tools: Cito, Tuto, Aha., and Hido.

Our focus is getting models into business workflows. From document intelligence to contract management to a general-purpose agent platform, the approach is the same: build a deployable product first, then take it into customers' production environments.

FIM operates through two companies: FIM Labs Pte. Ltd. in Singapore and Beijing FIM Network Technology Co., Ltd. in Beijing (founded 2013). The two are independent of each other and share the FIM brand.

Our Mission

To help every organization put AI to work in its business, not leave it stuck in a demo.

Product Journey

2021

Document Intelligence

Launched our first AI document intelligence product, beginning our productization journey.

2023

Zico

Released the Zico contract lifecycle management platform, extending the product line from document intelligence to contract management.

2025

One

Released One, a source-available agent framework, evolving from vertical products to a general-purpose platform.

2026

Research Tools

Launched Cito semantic paper search, Tuto citation-integrity auditing, the Aha. paper explainer, and Hido anonymous code hosting, extending the product line into research tools.

Core Team

Tao An

Tao An

Founder · FIM Labs

A decade in engineering, all-in on AI since 2021. Formalizes frontline practice into reproducible research and leads AI deployments across government and healthcare.

View background
  • A decade in engineering · AI deployments across government & healthcare
  • Author of One, a source-available agent platform
  • Paper published in the HHAI 2026 proceedings (IOS Press, open access) · ethics reviewer, NeurIPS 2026
Shuai Feng

Shuai Feng

Partner · Health Policy & Market Access

Background spans the pharma/medtech industry, academia, and regulation, working on health policy, drug pricing, health economics, and market access.

View background
  • Pharmaceutical Administration, Peking University (Shi Luwen research group); multiple NDRC research projects
  • Former NMPA Drug Certification Center; former NDRC pharmaceutical pricing division; DRG / DIP payment-policy drafter
  • Government affairs & market access at Bayer, Merck, J&J, Varian, AbbVie; multiple global President Awards
Yi Zhou

Yi Zhou

Chief Executive Officer

Over twelve years in company operations and management. CEO of FIM (Beijing) since 2016, responsible for strategy, fundraising, and key accounts.

View background
  • Previously at HPE, leading go-to-market for cloud computing in China
  • Joined FIM in 2016 as Chief Executive Officer
Jian Zhang

Jian Zhang

Technical Advisor · BCI / Neuro-AI

Associate Researcher and Master's Supervisor at the School of Medical Science and Engineering, Beijing Institute of Technology, working on brain science, brain-computer interfaces, and neuroengineering. He advises FIM on brain-computer interface and neuro-AI applications.

View background
  • Research spans EEG and fMRI analysis, brain functional networks and working-memory mechanisms, and imaging biomarkers of brain disorders such as Parkinson's disease
  • Recent work extends to LLM×BMI integration and brain-controlled robotics
  • Over 70 publications in NeuroImage, Communications Biology, IEEE TNSRE, and others

Certifications

ISO9001
ISO 9001

Quality Management

ISO27001
ISO/IEC 27001

Information Security Management

ISO20000
ISO/IEC 20000-1

IT Service Management

Certified entity: Beijing FIM Network Technology Co., Ltd. ISO certificates are verifiable at cx.cnca.cn.

Want to learn more?

Private deployment, integration, or just a closer look at what we build? Reach out directly.

Get in Touch